CVA Family Office’s Denali Therapeutics DNLI Stock Holding History

CVA Family Office’s Portfolio DNLI Stock Details DNLI Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.21K	Buy
2025 Q1	–	Sell
2024 Q4	$611	Hold
2024 Q3	$874	Hold
2024 Q2	$697	Buy